pubmed-article:18931650 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:18931650 | lifeskim:mentions | umls-concept:C0023434 | lld:lifeskim |
pubmed-article:18931650 | lifeskim:mentions | umls-concept:C0521447 | lld:lifeskim |
pubmed-article:18931650 | lifeskim:mentions | umls-concept:C0017262 | lld:lifeskim |
pubmed-article:18931650 | lifeskim:mentions | umls-concept:C0754136 | lld:lifeskim |
pubmed-article:18931650 | lifeskim:mentions | umls-concept:C2911684 | lld:lifeskim |
pubmed-article:18931650 | lifeskim:mentions | umls-concept:C0185117 | lld:lifeskim |
pubmed-article:18931650 | pubmed:issue | 12 | lld:pubmed |
pubmed-article:18931650 | pubmed:dateCreated | 2008-11-21 | lld:pubmed |
pubmed-article:18931650 | pubmed:abstractText | Aurora-A kinase is a cell-cycle-regulating kinase required for chromosomal segregation. Overexpression of Aurora-A kinase has been shown to correlate with tumor proliferation and chromosomal instability. We investigated Aurora-A kinase expression in peripheral blood and bone marrow of 47 chronic lymphocytic leukemia patients and 20 age-matched hematologically healthy subjects. Western blot analysis showed significantly higher Aurora-A levels in chronic lymphocytic leukemia (42 of 47) compared with lymphocytes of healthy subjects. However, Aurora-A mRNA expression in three chronic lymphocytic leukemia patients was similar to or lower than that of healthy control subjects. In 28 of 42 chronic lymphocytic leukemia patients with elevated Aurora-A kinase expression, one or more chromosomal abnormalities were detected, including trisomy 12 in 9 patients and deletion of the ataxia telangiectasia-mutated gene in 9 patients. Aurora-A was also detected in all (100%) chronic lymphocytic leukemia cases by immunohistochemistry, with a nuclear staining pattern. The larger prolymphocytes and paraimmunoblasts showed stronger Aurora-A kinase expression than did small lymphocytes. In contrast, normal bone marrow reactive lymphocytes were negative for Aurora-A with positive histiocytes and immature myeloid cells. Immunostaining for acetylated histone H3 showed a nuclear pattern in all 38 chronic lymphocytic leukemia cases and double labeling showed coexpression of acetylated histone H3 and Aurora-A. In summary, Aurora-A kinase is overexpressed in chronic lymphocytic leukemia cells. The expression of acetylated histone H3 suggests that Aurora-A kinase may be active (functional). Thus, Aurora-A kinase overexpression in chronic lymphocytic leukemia may be involved in the genesis of chromosomal abnormalities and is a potential target for therapeutic intervention. | lld:pubmed |
pubmed-article:18931650 | pubmed:language | eng | lld:pubmed |
pubmed-article:18931650 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18931650 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:18931650 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18931650 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18931650 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18931650 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18931650 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18931650 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:18931650 | pubmed:month | Dec | lld:pubmed |
pubmed-article:18931650 | pubmed:issn | 1530-0285 | lld:pubmed |
pubmed-article:18931650 | pubmed:author | pubmed-author:WangXuemeiX | lld:pubmed |
pubmed-article:18931650 | pubmed:author | pubmed-author:SenSubrataS | lld:pubmed |
pubmed-article:18931650 | pubmed:author | pubmed-author:MedeirosL... | lld:pubmed |
pubmed-article:18931650 | pubmed:author | pubmed-author:InamdarKedar... | lld:pubmed |
pubmed-article:18931650 | pubmed:author | pubmed-author:O'BrienSusanS | lld:pubmed |
pubmed-article:18931650 | pubmed:author | pubmed-author:KeatingMichae... | lld:pubmed |
pubmed-article:18931650 | pubmed:author | pubmed-author:Bueso-RamosCa... | lld:pubmed |
pubmed-article:18931650 | pubmed:author | pubmed-author:NguyenMartin... | lld:pubmed |
pubmed-article:18931650 | pubmed:author | pubmed-author:FernandezMich... | lld:pubmed |
pubmed-article:18931650 | pubmed:author | pubmed-author:ThomazyVilmos... | lld:pubmed |
pubmed-article:18931650 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:18931650 | pubmed:volume | 21 | lld:pubmed |
pubmed-article:18931650 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:18931650 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:18931650 | pubmed:pagination | 1428-35 | lld:pubmed |
pubmed-article:18931650 | pubmed:dateRevised | 2011-7-11 | lld:pubmed |
pubmed-article:18931650 | pubmed:meshHeading | pubmed-meshheading:18931650... | lld:pubmed |
pubmed-article:18931650 | pubmed:meshHeading | pubmed-meshheading:18931650... | lld:pubmed |
pubmed-article:18931650 | pubmed:meshHeading | pubmed-meshheading:18931650... | lld:pubmed |
pubmed-article:18931650 | pubmed:meshHeading | pubmed-meshheading:18931650... | lld:pubmed |
pubmed-article:18931650 | pubmed:meshHeading | pubmed-meshheading:18931650... | lld:pubmed |
pubmed-article:18931650 | pubmed:meshHeading | pubmed-meshheading:18931650... | lld:pubmed |
pubmed-article:18931650 | pubmed:meshHeading | pubmed-meshheading:18931650... | lld:pubmed |
pubmed-article:18931650 | pubmed:meshHeading | pubmed-meshheading:18931650... | lld:pubmed |
pubmed-article:18931650 | pubmed:meshHeading | pubmed-meshheading:18931650... | lld:pubmed |
pubmed-article:18931650 | pubmed:meshHeading | pubmed-meshheading:18931650... | lld:pubmed |
pubmed-article:18931650 | pubmed:meshHeading | pubmed-meshheading:18931650... | lld:pubmed |
pubmed-article:18931650 | pubmed:meshHeading | pubmed-meshheading:18931650... | lld:pubmed |
pubmed-article:18931650 | pubmed:meshHeading | pubmed-meshheading:18931650... | lld:pubmed |
pubmed-article:18931650 | pubmed:meshHeading | pubmed-meshheading:18931650... | lld:pubmed |
pubmed-article:18931650 | pubmed:meshHeading | pubmed-meshheading:18931650... | lld:pubmed |
pubmed-article:18931650 | pubmed:meshHeading | pubmed-meshheading:18931650... | lld:pubmed |
pubmed-article:18931650 | pubmed:meshHeading | pubmed-meshheading:18931650... | lld:pubmed |
pubmed-article:18931650 | pubmed:meshHeading | pubmed-meshheading:18931650... | lld:pubmed |
pubmed-article:18931650 | pubmed:meshHeading | pubmed-meshheading:18931650... | lld:pubmed |
pubmed-article:18931650 | pubmed:meshHeading | pubmed-meshheading:18931650... | lld:pubmed |
pubmed-article:18931650 | pubmed:year | 2008 | lld:pubmed |
pubmed-article:18931650 | pubmed:articleTitle | Aurora-A kinase nuclear expression in chronic lymphocytic leukemia. | lld:pubmed |
pubmed-article:18931650 | pubmed:affiliation | Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. | lld:pubmed |
pubmed-article:18931650 | pubmed:publicationType | Journal Article | lld:pubmed |
entrez-gene:6790 | entrezgene:pubmed | pubmed-article:18931650 | lld:entrezgene |
http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:18931650 | lld:entrezgene |
lhgdn:association:18585 | lhgdn:found_in | pubmed-article:18931650 | lld:lhgdn |